Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury

Journal of Surgical Research

Volumn 180, Issue 1, 2013, Pages 35-42

  Havelka, George E ^a,b   Moreira, Edward S ^a   Rodriguez, Monica P ^a   Tsihlis, Nick D ^a   Wang, Zheng ^a   Martínez, Janet ^a   Hrabie, Joseph A ^c   Kiefer, Larry K ^c   Kibbe, Melina R ^a,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Adventitia; Endoluminal; Inflammation; Intima; Macrophage; Media; Neointimal hyperplasia; Nitric oxide; Restenosis

Indexed keywords

NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL WALL THICKNESS; ARTERY PERMEABILITY; ARTICLE; BALLOON CATHETER; BALLOON EMBOLECTOMY; CAROTID ARTERY INJURY; CELL INFILTRATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACROPHAGE; NEOINTIMA; NEOINTIMAL HYPERPLASIA; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOPLASTY, BALLOON; ANIMALS; CAROTID ARTERY INJURIES; HYPERPLASIA; MALE; NEOINTIMA; NITRIC OXIDE; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84873707380     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.10.048     Document Type: Article

References (34)

1. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones Heart disease and stroke statistics-2012 update: a report from the American Heart Association Circulation 125 2012 e2
2. W.S. Weintraub, S.D. Clements Jr., and L.V. Crisco Twenty-year survival after coronary artery surgery: an institutional perspective from Emory University Circulation 107 2003 1271
3. A.W. Clowes, M.A. Reidy, and M.M. Clowes Mechanisms of stenosis after arterial injury Lab Invest 49 1983 208
4. M.G. Davies, H. Dalen, J.H. Kim, L. Barber, E. Svendsen, and P.O. Hagen Control of accelerated vein graft atheroma with the nitric oxide precursor: L-arginine J Surg Res 59 1995 35
5. H.E. von der Leyen, G.H. Gibbons, and R. Morishita Gene-therapy inhibiting neointimal vascular lesion-in-vivo transfer of endothelial-cell nitric-oxide synthase gene Proc Natl Acad Sci U S A 92 1995 1137
6. J.S. Lee, C. Adrie, H.J. Jacob, J.D.J. Roberts, W.M. Zapol, and K.D. Bloch Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury Circ Res 78 1996 337
7. D.S. Marks, J.A. Vita, J.D. Folts, J.F. Keaney Jr., G.N. Welch, and J. Loscalzo Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide J Clin Invest 96 1995 2630
8. A. Chaux, X.M. Ruan, and M.C. Fishbein Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation J Thorac Cardiovasc Surg 115 1998 604
9. P.S. Fleser, V.K. Nuthakki, and L.E. Malinzak Nitric oxide-releasing biopolymers inhibit thrombus formation in a sheep model of arteriovenous bridge grafts J Vasc Surg 40 2004 803
10. L.L. Shears, M.R. Kibbe, and A.D. Murdock Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo J Am Coll Surg 187 1998 295
11. C.G. Pearce, S.F. Najjar, and M.R. Kapadia Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia Free Radic Biol Med 44 2008 73
12. J. Harnek, E. Zoucas, V.P. de Sa, E. Ekblad, A. Arner, and U. Stenram Intimal hyperplasia in balloon dilated coronary arteries is reduced by local delivery of the NO donor, SIN-1 via a cGMP-dependent pathway BMC Cardiovasc Disord 11 2011 30
13. S.S. Ahanchi, V.N. Varu, and N.D. Tsihlis Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome Am J Physiol Heart Circ Physiol 295 2008 H2388
14. M.R. Kapadia, L.W. Chow, and N.D. Tsihlis Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia J Vasc Surg 47 2008 173
15. A.K. Vavra, G.E. Havelka, and J. Martinez Insights into the effect of nitric oxide and its metabolites nitrite and nitrate at inhibiting neointimal hyperplasia Nitric Oxide 25 2011 22
16. P. Kubes, M. Suzuki, and D.N. Granger Nitric oxide: an endogenous modulator of leukocyte adhesion Proc Natl Acad Sci U S A 88 1991 4651
17. M.J. Hickey, K.A. Sharkey, and E.G. Sihota Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia FASEB J 11 1997 955
18. G.F. Rich, C.M. Roos, S.M. Anderson, D.C. Urich, M.O. Daugherty, and R.A. Johns Inhaled nitric-oxide - dose response and the effects of blood in the isolated rat lung J Appl Physiol 75 1993 1278
19. D.B. McNamara, B. Bedi, and H. Aurora L-arginine inhibits balloon catheter-induced intimal hyperplasia Biochem Biophys Res Commun 193 1993 291
20. C. Chen, S.G. Mattar, and A.B. Lumsden Oral administration of L-arginine reduces intimal hyperplasia in balloon-injured rat carotid arteries J Surg Res 82 1999 17
21. C. Napoli, G. Cirino, and P. Del Soldato Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice Proc Natl Acad Sci U S A 98 2001 2860
22. P.H. Groves, A.P. Banning, W.J. Penny, A.C. Newby, H.A. Cheadle, and M.J. Lewis The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty Cardiovasc Res 30 1995 87
23. J. Wohrle, M. Hoher, T. Nusser, V. Hombach, and M. Kochs No effect of highly dosed nitric oxide donor molsidomine on the angiographic restenosis rate after percutaneous coronary angioplasty: a randomized, placebo controlled, double-blind trial Can J Cardiol 19 2003 495
24. J.M. Lablanche, G. Grollier, and J.R. Lusson Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD Study. Angioplastic Coronaire Corvasal Diltiazem Circulation 95 1997 83
25. J. Harnek, E. Zoucas, and R. Sjuve Local infusion of the nitric oxide donor Sin-1 after angioplasty. Effects on intimal hyperplasia in porcine coronary arteries Acta Radiol 44 2003 395
26. G.J. Fulton, M.G. Davies, L. Barber, J.L. Gray, E. Svendsen, and P.O. Hagen Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts Eur J Vasc Endovasc 15 1998 279
27. P.H. Rolland, C. Mekkaoui, and M. Palassi Efficacy of local molsidomine delivery from a hydrogel-coated angioplasty balloon catheter in the atherosclerotic porcine model Cardiovasc Intervent Radiol 26 2003 65
28. R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 1993 801
29. K. Yokote, A. Take, and C. Nakaseko Bone marrow-derived vascular cells in response to injury J Atheroscler Thromb 10 2003 205
30. N.M. Tigerstedt, H. Savolainen-Peltonen, S. Lehti, and P. Hayry Vascular cell kinetics in response to intimal injury ex vivo J Vasc Res 47 2010 35
31. G. Li, S.J. Chen, S. Oparil, Y.F. Chen, and J.A. Thompson Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries Circulation 101 2000 1362
32. J.N. Wilcox, R. Waksman, S.B. King, and N.A. Scott The role of the adventitia in the arterial response to angioplasty: the effect of intravascular radiation Int J Radiat Oncol Biol Phys 36 1996 789
33. Y. Shi, J.E. Obrien, A. Fard, J.D. Mannion, D. Wang, and A. Zalewski Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries Circulation 94 1996 1655
34. E. Okamoto, T. Couse, and L.H. De Perivascular inflammation after balloon angioplasty of porcine coronary arteries Circulation 104 2001 2228